NPS Pharma Stock Trading Halted Today; FDA Advisory Committee to Review Natpara Biologics License Application
September 12, 2014 at 07:07 AM EDT
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the ...